These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Penicillin Allergy Evaluation Should Be Performed Proactively in Patients With a Penicillin Allergy Label. ; J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3626-3628. PubMed ID: 37838278 [TBL] [Abstract][Full Text] [Related]
31. Inconsistencies in penicillin allergy labels in hospital and primary care after allergy investigation. Fransson S; Boel JB; Holm A; Kahlhofen N; Hjortlund J; Mosbech HF; Poulsen LK; Reventlow S; Garvey LH Clin Exp Allergy; 2023 Sep; 53(9):969-973. PubMed ID: 37246612 [No Abstract] [Full Text] [Related]
32. Single-step direct drug provocation testing is safe for delabelling selected non-low-risk penicillin allergy labels. Li J; Cvetanovski V; Fernando S Ann Allergy Asthma Immunol; 2021 Aug; 127(2):232-235. PubMed ID: 33865989 [TBL] [Abstract][Full Text] [Related]
33. Inpatient β-lactam test-dose protocol and antimicrobial stewardship in patients with a history of penicillin allergy. Sacco KA; Cochran BP; Epps K; Parkulo M; Gonzalez-Estrada A Ann Allergy Asthma Immunol; 2019 Feb; 122(2):184-188. PubMed ID: 30465860 [TBL] [Abstract][Full Text] [Related]
34. Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital. du Plessis T; Walls G; Jordan A; Holland DJ J Antimicrob Chemother; 2019 May; 74(5):1438-1446. PubMed ID: 30753497 [TBL] [Abstract][Full Text] [Related]
35. Non-invasive delabeling and refining of beta-lactam allergy labels in inpatients to optimize antimicrobial stewardship. Van De Sijpe G; Gilissen L; Vandebotermet M; Peetermans WE; Spriet I; Schrijvers R Allergy; 2022 Oct; 77(10):3157-3159. PubMed ID: 35876226 [No Abstract] [Full Text] [Related]
36. Prospective, Multicenter, Head-to-Head Comparison Between Allergists Versus Nonallergists in Low-Risk Penicillin Allergy Delabeling: Effectiveness, Safety, and Quality of Life (HK-DADI2). Wong JCY; Kan AKC; Chik TSH; Chu MY; Li TCM; Mak HWF; Chiang V; Li PH J Allergy Clin Immunol Pract; 2024 Jul; 12(7):1801-1808.e2. PubMed ID: 38631522 [TBL] [Abstract][Full Text] [Related]
37. The democratization of de-labeling: a review of direct oral challenge in adults with low-risk penicillin allergy. Rose MT; Slavin M; Trubiano J Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1143-1153. PubMed ID: 32662696 [TBL] [Abstract][Full Text] [Related]
38. DALES, Drug Allergy Labels in Elective Surgical patients: a prospective multicentre cross-sectional study of incidence, risks, and attitudes in penicillin de-labelling strategies. Savic L; Thomas C; Fallaha D; Wilson M; Hopkins PM; Savic S; Clark SH; Br J Anaesth; 2020 Dec; 125(6):962-969. PubMed ID: 32859363 [TBL] [Abstract][Full Text] [Related]
39. A multidimensional antimicrobial stewardship intervention targeting aztreonam use in patients with a reported penicillin allergy. Swearingen SM; White C; Weidert S; Hinds M; Narro JP; Guarascio AJ Int J Clin Pharm; 2016 Apr; 38(2):213-7. PubMed ID: 26768137 [TBL] [Abstract][Full Text] [Related]
40. Penicillin skin testing in hospitalized patients with β-lactam allergies: Effect on antibiotic selection and cost. King EA; Challa S; Curtin P; Bielory L Ann Allergy Asthma Immunol; 2016 Jul; 117(1):67-71. PubMed ID: 27211057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]